-
July 12: The Week in Cancer NewsStandard screening may not catch endometrial cancer in Black women, and a cancer patient receives a voice box transplant for the first time.
by Thomas Celona
-
More Patients Participating in Cancer ResearchA higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
-
July 5: The Week in Cancer NewsNeuropathy may be prevented with an exercise program, and prostate cancer screening standards may not be appropriate for transgender women taking estrogen.
by Eric Fitzsimmons
-
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung CancerThe drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore
-
June 28: The Week in Cancer NewsAcupuncture helps manage side effects of endocrine therapy, and adding chemotherapy before surgery delays progression in pancreatic cancer.
by Marci A. Landsmann
-
Self-collection Broadens Access to HPV ScreeningFDA approval allows patients to collect samples for HPV test, lowering a barrier to an important cancer prevention tool.
by Taneia Surles
-
June 21: The Week in Cancer NewsRisk for cancer and cardiovascular disease linked to air pollution, and three cancer drugs could face generic competition by 2028.
by Kevin McLaughlin
-
June 14: The Week in Cancer NewsLung cancer screening linked to lower mortality in real-world data, and researchers study unusual cancer patterns after COVID-19 infection.
by Eric Fitzsimmons
-
To Understand Disparities, Look at the Broader ContextsResearchers at the AACR Annual Meeting 2024 consider ways in which social and economic factors like location affect cancer risk and outcomes.
by Eric Fitzsimmons
-
June 7: The Week in Cancer NewsResearch supports reducing the intensity of cancer treatment, and barriers can prevent members of the LGBTQ+ community from receiving cancer screening and care.
by Thomas Celona
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
